Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for 'Off' Episodes in Late Stage Parkinson's Disease
NCT00200512Phase 3Completed
- Sponsor
- Viatris
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of apomorphine in Parkinson's disease (PD) (2 arms), sponsored by Viatris. Primary endpoint: Unified Parkinson's Disease Rating Scale Motor Score. Started Sep 1999; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00200512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200512.